Clinical trial DRKS00010936
Status: Recruiting (according to the registry)Observational studyLatest change: Source: DRKS (Germany) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in August 16, 2016 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)
- Record number
- DRKS00010936
- Registry
- DRKS (Germany) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Observational study
- Participants
- Target: 600
- Condition (as registered)
- DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosis
- Countries
- Germany
- Topic in the guide
- Schizophrenia
Timeline
According to the DRKS (Germany) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: August 16, 2016
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Schizophrenia: guide page · Thinking of taking part? Which specialist to see